EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Next-Generation Minimally Invasive Anti-Aging Therapy: Incorporation of Resveratrol-Nicotinamide Cerosomes into PLGA Microneedles for Enhanced Skin Permeation

Sammar Fathy Elhabal iD, Mai S Shoela, Fatma E Hassan iD, Suzan Awad AbdelGhany Morsy iD, Amal M Elsharkawy, Amany Ali Khalil Nawar iD, Mona Mohamed Ahmed, Shady Allam iD, Marwa A Fouad iD, Amal Anwar Taha iD, Ahmed Mohsen Faheem, Hanan Mohamed Abd Elmoneim iD und 1 weitere

Pharmaceutics · 04.03.2026 · 18 (3) · 326

DOI: 10.3390/pharmaceutics18030326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 04.03.2026. Verfasst von Sammar Fathy Elhabal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Mokattam, Cairo 115…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Skin aging and wrinkle formation are primarily driven by ultraviolet (UV)-induced oxidative stress and inflammation. Resveratrol (RSV) and nicotinamide (NCT) possess potent anti-aging properties but suffer from poor skin penetration. This study aimed to develop an advanced transdermal delivery system incorporating RSV/NCT-loaded cerosomes within poly(lactic-co-glycolic acid) (PLGA) microneedles to enhance skin permeation and anti-aging performance.

Methods

RSV/NCT-loaded cerosomes were formulated using thin-film hydration of phosphatidylcholine, ceramides (III, IIIB, and VI), and poloxamer surfactants, subsequently optimized via a D-optimal mixture design. PLGA microneedles with optimized cerosomes were tested for their mechanical strength, penetration, drug loading, and release. Ex vivo permeation and in vivo evaluations were performed using a UVA-induced skin wrinkling model.

Results

Optimized cerosomes exhibited high entrapment efficiency for RSV and NCT (91 ± 0.56% and 85 ± 0.56%, respectively), nanoscale size (195 ± 0.78 nm), low polydispersity (0.23 ± 0.01), and a negative zeta potential (−22 ± 0.45 mV). PLGA microneedles exhibited sufficient mechanical integrity and effective penetrability through Parafilm® layers. Microneedle-loaded cerosomes enabled sustained drug release (approximately 65–70% over 48 h) and enhanced ex vivo permeation, approximately for NCT and RSV (1450 μg/cm2 and 1000 μg/cm2, respectively). In vivo investigations revealed improved skin appearance, restoration of epidermal thickness and collagen architecture, reduced levels of inflammatory cytokines (TNF-α, IL-1β, IL-6, NLRP3), reduced oxidative stress biomarkers (GSH, GPx, MDA, SOD), and genetic upregulation of VEGF, TGF-β1, and β-Catenin.

Conclusions

The RSV/NCT cerosome-encapsulated PLGA microneedle system offers a promising, minimally invasive approach with superior transdermal delivery, sustained efficacy, and significant anti-aging benefits.

Schlagwörter

Stichwörter der Autor:innen

PLGAanti-wrinkle therapycerosomesmicroneedle-based systemsnicotinamideresveratrolskin agingskin delivery

Autor:innen und Institutionen

  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Mokattam, Cairo 11571, Egypt.
  • Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt.
  • Department of Physiology, General Medicine Practice Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.
  • Medical Physiology Department, Faculty of Medicine, Cairo University, Kasr Alainy, Giza 11562, Egypt.
  • Pathological Sciences Department, MBBS Program, Fakeeh College for Medical Sciences, Jeddah 21461, Saudi Arabia.
  • Department of Biophysiology, Ibn Sina National College for Medical Studies, Jeddah 22421, Saudi Arabia.

ORCID-Profile: Sammar Fathy Elhabal, Fatma E Hassan, Suzan Awad AbdelGhany Morsy, Amany Ali Khalil Nawar, Shady Allam, Marwa A Fouad, Amal Anwar Taha, Hanan Mohamed Abd Elmoneim, Ahmed Mohsen Elsaid Hamdan

Zitieren

APA

Elhabal, S. F., Shoela, M. S., Hassan, F. E., Morsy, S. A. A., Elsharkawy, A. M., Nawar, A. A. K., Ahmed, M. M., Allam, S., Fouad, M. A., Taha, A. A., Faheem, A. M., Abd Elmoneim, H. M., & Hamdan, A. M. E. (2026). Next-Generation Minimally Invasive Anti-Aging Therapy: Incorporation of Resveratrol-Nicotinamide Cerosomes into PLGA Microneedles for Enhanced Skin Permeation. Pharmaceutics, 18(3), 326. https://doi.org/10.3390/pharmaceutics18030326

Vancouver

Elhabal SF, Shoela MS, Hassan FE, Morsy SAA, Elsharkawy AM, Nawar AAK, et al. Next-Generation Minimally Invasive Anti-Aging Therapy: Incorporation of Resveratrol-Nicotinamide Cerosomes into PLGA Microneedles for Enhanced Skin Permeation. Pharmaceutics. 2026;18(3):326. doi:10.3390/pharmaceutics18030326

BibTeX
@article{Elhabal2026,
  author = {Elhabal, Sammar Fathy and Shoela, Mai S and Hassan, Fatma E and Morsy, Suzan Awad AbdelGhany and Elsharkawy, Amal M and Nawar, Amany Ali Khalil and Ahmed, Mona Mohamed and Allam, Shady and Fouad, Marwa A and Taha, Amal Anwar and Faheem, Ahmed Mohsen and Abd Elmoneim, Hanan Mohamed and Hamdan, Ahmed Mohsen Elsaid},
  title = {Next-Generation Minimally Invasive Anti-Aging Therapy: Incorporation of Resveratrol-Nicotinamide Cerosomes into PLGA Microneedles for Enhanced Skin Permeation},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {326},
  doi = {10.3390/pharmaceutics18030326}
}
Kostenlos starten →